Drug Delivery Technologies Market Forecast 2014-2024

ドラッグデリバリー技術市場(2014-2024)

◆タイトル:Drug Delivery Technologies Market Forecast 2014-2024
◆商品コード:Visiongain-405315
◆調査・発行会社:visiongain
◆発行日:2014年4月
◆ページ数:202
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single user licence(1名使用)GBP1,799 ⇒換算¥266,252見積依頼/購入/質問フォーム
Dept Licence(部署内共有可)GBP2,999 ⇒換算¥443,852見積依頼/購入/質問フォーム
Site Licence(同一国内社内共有可)GBP4,999 ⇒換算¥739,852見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"ドラッグデリバリー技術市場(2014-2024)"について調査・分析し、レポートサマリー、市場の促進要因、抑制要因、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、専門家の見解、主要企業分析などの情報をお届けいたします。

Drug Delivery Technologies – new study showing you trends, R&D progress, and predicted revenues
Where is the drug delivery technologies market heading? What are the commercial prospects for this market and related technologies? Visiongain’s new report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects.
Our 202 page report provides 157 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at world market, submarket and national level. You will see financial results, interviews, trends, opportunities and revenue predictions.
Forecasts from 2014-2024 and other analyses show you commercial prospects
Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
• Dr. Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark
• Dr. Claus Michael Lehr, Head of Department, Drug Delivery at Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
You find prospects for key submarkets
In addition to analyses of the overall world market, you see revenue forecasting of six world-level submarkets to 2024:
• Nasal drug delivery technologies market
• Ocular drug delivery technologies market
• Transdermal drug delivery technologies market
• Injectable/implants drug delivery technologies market
• Inhalation drug delivery technologies market
• Oral drug delivery technologies market
How will biological drugs using these technologies perform from 2014? You will find overall revenues from nine pharmaceutical areas predicted to 2024:
• Recombinant coagulation factors
• Insulins
• Monoclonal antibodies
• G-CSF agents
• Erythropoietins
• Interferons
• Biosimilars and related agents
• Vaccines
• Other therapeutic proteins
Technologies and applications giving improved clinical efficacy, patient convenience and treatment compliance will achieve success. In particular, greater use of injectable drugs and vaccines worldwide will stimulate demand for innovative delivery systems.
Our investigation shows business research and analysis with individual revenue forecasts and discussions. You find dynamics of the industry and assess its potential sales, seeing technologies likely to achieve the most success.
What are the prospects for the leading regions and countries?
In addition to analyses of the overall world market, you discover individual revenue forecasts for 13 national markets to 2024:
• US
• Japan
• Germany
• France
• UK
• Italy
• Spain
• Brazil
• Russia
• India
• China
• Mexico
• South Korea
• Rest of the World
Regulatory, demographic and commercial developments worldwide will influence the market, especially fast-rising demand in emerging markets.
Increasing development and use of biological drugs (biologics) will increase worldwide sales of drug delivery technologies from 2014 to 2024, our study shows.
Leading companies and potential for market growth
Overall world revenue for drug delivery technologies will reach $138.1bn in 2014, our work forecasts. We predict steady growth from 2014 to 2024. Our work shows you what organisations hold greatest potential. See profiles of 18 leading companies, including these:
• 3M
• Aradigm Corporation
• Vectura Group
• Applied Pharma Research
• Catalent Pharma Solutions
• Emisphere Technologies
• Ethypharm
• Glycologic
• Alkermes
• Antares Pharma
• Bioject Medical Technologies
• Pacira Pharmaceuticals
• Nanopass Technologies
• Noven Pharmaceuticals
• CIMA Labs
• Columbia Laboratories
• Generex Biotechnology Corporation
• pSivida
A company profile gives you the following information:
• Overview of the company, including its history in the market
• Recent financial results
• Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures
• Discussion of a company’s activities and outlook including descriptions of leading products
What issues will affect the drug delivery technologies market?
Our new report discusses issues and events affecting the drug delivery technologies market. You will find discussions of many issues and developments, including R&D:
• Cost savings and efficiencies
• Drug delivery technologies as tools for product lifecycle management
• Retention of product exclusivity
• Optimising the therapeutic value of drugs
• Safety and patient compliance
• Product differentiation and customisation
• Reimbursement and legislation
Our investigation gives you multi-level business research and analysis with sales forecasts. You see how that industry and market can perform from 2014 to 2024.
How the Drug Delivery Technologies Market Forecast 2014-2024: Opportunities for Leading Companies report helps you
In summary our 202-page report gives you the following knowledge:
• Revenues to 2024 for the overall world drug delivery technologies market and 6 submarkets – discover that industry’s prospects, finding promising areas for investments and revenues
• Assessment of biological drug markets – discover prospects for drug delivery technologies from 2014.
• Revenue forecast to 2024 for the leading 13 national markets – US, Japan, Germany, France, the UK, Italy, Spain, Brazil, Russia, India, China, Mexico, South Korea and Rest of the World
• Assess 18 leading companies – hear about products, results and strategies including recent activities and outlook.
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
• Opinions from our survey, seeing interviews with industry authorities.
You will find quantitative and qualitative analyses with independent predictions. You receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

【レポートの目次】

1. Report Overview
1.1 Global Drug Delivery Technologies Market Overview
1.2 Global Drug Delivery Technologies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction to Drug Delivery
2.1 Drug Delivery Technologies (DDT)
2.2 Drug Delivery Technologies – Types
2.2.1 Injection As a Route of Drug Delivery
2.2.2 Needle-free Transdermal Delivery
2.2.3 Oral Delivery Technologies
2.2.4 Inhalation or Spray
2.3 Sustained/Controlled Release Systems
2.4 Biopharmaceuticals
2.4.1 An introduction to the Biologic Drugs Market
2.4.2 Biologics: A Rising Drugs Market
2.4.3 Biotech Drugs with Associated Drug Delivery Technologies
2.4.4 Pegylated Interferons
2.4.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.4.6 The Main Challenges Facing Biological Drug Delivery
2.5 Market Definition
3. The Global Drug Delivery Technologies Market, 2014-2024
3.1 Global Drug Delivery Technologies: Market Overview
3.1.1 Drug Delivery Technologies: A Growing Market
3.2 The Global Drug Delivery Technologies Market in 2013
3.2.1 Global Drug Delivery Technologies: Market Forecast 2014-2024
3.2.2 Changing Market Shares by Sector 2014-2024
3.3 Oral Drug Delivery Technologies Market 2014-2024
3.3.1 Oral Drug Delivery Technologies: Market Forecast 2014-2024
3.4 Inhalation Drug Delivery Technologies Market 2014-2024
3.4.1 Inhalation Drug Delivery Technologies: Market Forecast 2014-2024
3.5 Injectable/Implants Drug Delivery Technologies Market 2014-2024
3.5.1 Injectable/Implants Drug Delivery Technologies: Market Forecast 2014-2024
3.6 Transdermal Drug Delivery Technologies Market 2014-2024
3.6.1 Transdermal Drug Delivery Technologies: Market Forecast 2014-2024
3.7 Ocular Drug Delivery Technologies Market 2014-2024
3.7.1 Ocular Drug Delivery Technologies: Market Forecast 2014-2024
3.8 Nasal Drug Delivery Technologies Market 2014-2024
3.8.1 Nasal Drug Delivery Technologies: Market Forecast 2014-2024
4. Leading National Markets 2014-2024
4.1 The Drug Delivery Technologies Market by Regional Revenue
4.1.1 The Global Distribution of Drug Delivery Technologies in 2013
4.2 Leading National Markets: Forecast, 2014-2024
4.2.1 Changing Market Shares by Region, 2014-2024
4.3 Regional Drug Delivery Technologies Markets: Analysis and Forecasts, 2014-2024
4.3.1 United States: The Largest Market for Drug Delivery Technologies
4.3.2 The EU5 Markets:
4.3.2.1 EU5: Changing Market Shares by Country, 2014-2024
4.3.2.2 Germany: Fiscal Austerity Programs and Spending Cuts
4.3.2.3 France: Strong Drug Discovery Landscape
4.3.2.4 UK: An Increasingly Service-Oriented Market
4.3.2.5 Spain: Recovering Economy to Stimulate Healthcare Investment
4.3.2.6 Italy: Changing Reimbursement Culture Will Aid Market Growth
4.3.3 Japan: Aging Population Stimulating Drug Demand
4.3.4 China: Intensive Talent Resource and Relative Low Cost
4.3.5 India: A Hotbed For Drug Delivery Technology Manufacturing and Outsourcing
4.3.6 Brazil: Government Subsidies Boosting Drug Production
4.3.7 Russia: Availability of Custom Libraries for Drug Molecules Will Catalyse Growth
4.3.8 South Korea: Acquisition of Promising Overseas Companies Will Aid Market Growth
4.3.9 Mexico: Government Initiatives and Regulatory Changes Boosting Market Growth
4.3.10 Rest of the World
5. Leading Drug Classes Offering Growth for Drug Delivery Technologies
5.1 Therapeutic Areas Offering Growth Opportunities
5.2 Biologics: A Future Driver for Growth in Drug Delivery Technologies
5.2.1 Leading Classes of Biological Drugs, 2013
5.3 Monoclonal Antibodies: Largest Sector in Biologics
5.3.1 Monoclonal Antibodies: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.4 Human Insulins
5.4.1 Insulins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.4.2 Exubera: An Alternative Delivery Method for Biological Drugs
5.4.2.1 The First Inhaled Insulin
5.4.2.2 A History of Exubera: Development and Post-Marketing
5.4.3 Generex and MannKind Developing Next-Generation Oral Insulins
5.4.4 Challenges Facing Oral-lyn and Afrezza
5.5 Interferons
5.5.1 Interferons: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.6 Erythropoietin Products
5.6.1 Erythropoietins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.7 Granular-Colony Stimulating Factors (G-CSF)
5.7.1 Granular-Colony Stimulating Factors (G-CSF): Prospects, Forecast, and Implications for Drug Delivery Technologies
5.8 Recombinant Coagulation Factors
5.8.1 Recombinant Coagulation Factors: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.9 Other Therapeutic Proteins
5.9.1 Other therapeutic Proteins: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.10 The Biosimilars Market in 2013
5.10.1 Biosimilars: Prospects, Forecast, and Implications for Drug Delivery Technologies
5.11 The Vaccines Market in 2013
5.11.1 Vaccines: Market Forecast 2014-2024
5.12 The Role of Biologics in the Drug Delivery Technologies Market
6. Leading Companies in the Drug Delivery Technologies Market, 2014
6.1 Drug Delivery Technologies: A Fragmented Market
6.2 Leading Companies in Inhaled Drug Delivery Technologies
6.2.1 3M: A Global Health Information Systems Provider
6.2.1.1 3M Healthcare Revenue Analysis, 2013
6.2.1.2 3M’s Drug Delivery Technologies
6.2.1.2.1 Protein and Peptide Delivery
6.2.1.2.2 Excipient Technology for CFC-Free Inhalers
6.2.1.2.3 Actuator Technology for Metered Dose Inhalers
6.2.1.2.4 Particle Engineering Technology
6.2.2 Aradigm Corporation
6.2.2.1 AERx Drug Delivery System
6.2.2.2 Aradigm’s Partnerships
6.2.2.3 Aradigm’s Pipeline Products
6.2.3 Vectura Group
6.2.3.1 Vectura’s Technologies and Products
6.2.3.2 Vectura’s Development Pipeline
6.3 Leading Companies in Oral Drug Delivery Technologies
6.3.1 Applied Pharma Research (APR)
6.3.1.1 APR’s Technology and Product Offerings
6.3.2 Catalent Pharma
6.3.2.1 Catalent’s Drug Delivery Technologies
6.3.2.2 Catalent Revenue Analysis, 2009-2013
6.3.2.3 Catalent’s Recent Activities
6.3.3 Emisphere Technologies
6.3.3.1 Emisphere’s Eligen Technology
6.3.3.2 Emisphere Revenue Analysis, 2010-2013
6.3.3.3 Emisphere: Pipeline Products
6.3.4 Ethypharm
6.3.4.1 Ethypharm’s Drug Delivery Technologies
6.3.4.2 Ethypharm’s Currently Marketed Products
6.3.5 Glycologic
6.3.5.1 Glycologic’s Drug Delivery Technologies
6.3.5.2 Glycologic’s Pipeline Developments
6.4 Leading Companies in Injectable Drug Delivery Technologies
6.4.1 Alkermes
6.4.1.1 Alkerme’s Drug Delivery Technologies
6.4.1.2 Alkermes Revenue Analysis, 2009-2013
6.4.1.3 Alkerme’s Product Pipeline
6.4.2 Pacira Pharmaceuticals
6.4.2.1 Pacira’s Injectable Sustained–Release Technologies
6.4.2.2 Pacira Pharmaceuticals: Revenue Analysis, 2009-2013
6.5 Leading Companies in Transdermal Drug Delivery Technologies
6.5.1 Nanopass Technologies
6.5.1.1 Nanopass Drug Delivery Products
6.5.1.1.1 Anti-aging Microdermabrasion
6.5.1.1.2 Microjet Needle
6.5.2 Noven Pharmaceuticals
6.5.2.1 Noven Pharmaceuticals’ Transdermal Products
6.5.2.2 Noven’s Development Pipeline
6.6 Leading Companies for Transmucosal Drug Delivery
6.6.1 CIMA Labs
6.6.1.1 CIMA’s Transmucosal Drug Delivery Technologies
6.6.1.2 The OTS System
6.6.1.3 OraVescent Technology
6.6.2 Columbia Laboratories
6.6.2.1 Columbia Labs’ Bioadhesive Delivery Technology
6.6.2.2 Columbia Labs’ Products
6.6.2.3 Columbia Labs Revenue Analysis, 2009-2013
6.6.3 Generex Biotechnology Corporation
6.6.3.1 Generex’s Products
6.6.3.2 Generex: Revenue Analysis, 2011-2013
6.7 Leading Implantable Drug Delivery Technology Companies
6.7.1 pSivida Corporation
6.7.1.1 pSivida’s Drug Delivery Technologies
6.7.1.1.1 Durasert Technology
6.7.1.1.2 Tethadur Technology
6.7.2 pSivida Products
7. Qualitative Analysis of the Drug Delivery Technologies Market 2014-2024
7.1 SWOT Analysis of the Drug Delivery Technologies Market, 2014-2024
7.2 Strengths
7.2.1 Biosimilars: Legislations Encouraging Innovation
7.2.2 Patent Expiries and the Resulting Increase in Competition Will Favour Drug Delivery Technologies
7.2.3 Monoclonal Antibodies Will Drive Delivery Technologies
7.2.4 PEGylation Assisting Growth
7.3 Weaknesses
7.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
7.4 Opportunities
7.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
7.4.2 Possible New Delivery Methods for Insulin
7.4.3 Availability of Cost effective Solutions Will Stimulate Uptake of Drug Delivery Technologies
7.5 Threats
7.5.1 The Conservative Mindset of Drug Developers May Hinder Innovation in Drug Delivery
7.5.2 The Current Limit on Feasible Route of Administration for Biotech Drugs May Limit Drug Delivery Growth
7.5.3 Lifecycle Management via Protein Engineering Blurs Drug Delivery Lines
8. Expert Opinions
8.1 Interview with Dr Sven Frokjaer, Dean and Professor of Pharmaceutical Sciences, University of Copenhagen, Denmark
8.1.1 On the Current State of Drug Delivery Technologies
8.1.2 The ‘Magic Bullet’ – A Challenge for Innovation
8.1.3 Self-Assembling Protein Systems and the Use of Nanostructures for Drug Targeting
8.1.4 Technological Developments in Drug Development – Quantum Dots, Silicon Structures, and Polymeric Materials
8.1.5 On Future Challenges and Opportunities
8.2 Interview with Dr Claus Michael Lehr, Head of Department, Drug Delivery at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
8.2.1 The Need for Novel Delivery Mechanisms Driving Growth
8.2.2 Therapeutic Areas That Are Propelling Drug Delivery Technologies
8.2.3 Drug Delivery Barriers and the Need for Targeting
8.2.4 Advancements in Drug Delivery in the Coming Years
8.2.5 Future Challenges for Drug Delivery Technologies
8.2.6 Future Opportunities for Drug Delivery Technologies
9. Conclusion
9.1 Market Overview
9.2 Commercial Drivers for Drug Delivery Technology
9.3 Transdermal Drug Delivery Technologies Set For High Growth
9.4 Biologics Will Drive Market Growth
9.5 Leading Companies in the Drug Delivery Technologies Market
9.6 Growth Concentrated in Developed Markets and in the Innovative Markets of South America and South Asia
9.7 Future Prospects for Drug Delivery Technologies

List of Tables
Table 2.1 Top 10 Biotech Drugs by Sales ($bn), 2013
Table 2.2 Top 10 Biopharma Companies: Revenues ($m) & R&D Expenditure ($m), 2012
Table 2.3 Amino Acid Changes for Human Insulin Analogues
Table 3.1 Functions of Drug Delivery Technologies
Table 3.2 The Global Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Sector, 2013
Table 3.3 The Global Drug Delivery Technologies Market: Market Forecast ($bn, AGR%, CAGR%) by Sector, 2013-2024
Table 3.4 Global Drug Delivery Technologies Market Forecast: CAGR (%) by Sector, 2013-2018, 2018-2024, 2013-2024
Table 3.5 The Global Drug Delivery Technologies Market: Revenue ($bn) by Sector, 2013, 2018, 2024
Table 3.6 The Global Drug Delivery Technologies Market: Market Share (%) by Sector, 2013, 2018, 2024
Table 3.7 Oral Drug Delivery Technologies Market: Market Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 3.8 Inhalation Drug Delivery Technologies Market: Market Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 3.9 Injectable/Implants Drug Delivery Technologies Market: Market Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 3.10 Transdermal Drug Delivery Technologies Market: Market Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 3.11 Ocular Drug Delivery Technologies Market: Market Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 3.12 Nasal Drug Delivery Technologies Market: Market Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.1 The Global Drug Delivery Technologies Market: Revenue ($bn) and Market Share (%) by Region, 2013
Table 4.2 Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%, CAGR%) by Region, 2013-2024
Table 4.3 Drug Delivery Technologies Market Forecast: CAGR (%) by Region, 2013-2018, 2018-2024, and 2013-2024
Table 4.4 Drug Delivery Technologies Market Forecast: Market Shares (%) by Region, 2013, 2018, 2024
Table 4.5 US Drug Delivery Technologies Market Forecast: Revenue ($bn), Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.6 US Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.7 The EU5 Drug Delivery Technologies Market Forecast: Market Size ($bn), Market Share (%) and CAGR (%), 2013-2024
Table 4.8 The EU5 Drug Delivery Technologies Market: Revenue ($bn) and Market Share (%) by Country, 2013
Table 4.9 The EU5 Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%, CAGR%) by Region, 2013-2024
Table 4.10 EU5 Drug Delivery Technologies Market: Market Share (%) by Country, 2013, 2018, 2024
Table 4.11 The German Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.12 The German Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.13 The French Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.14 The French Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.15 The UK Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.16 The UK Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.17 The Spanish Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.18 The Spanish Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.19 The Italian Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.20 The Italian Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.21 The Japanese Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.22 The Japanese Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.23 The Chinese Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.24 The Chinese Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.25 The Indian Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.26 The Indian Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.27 The Brazilian Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.28 The Brazilian Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.29 The Russian Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.30 The Russian Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.31 The South Korean Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.32 The South Korean Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.33 The Mexican Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Rank, Market Share (%) and CAGR (%), 2013-2024
Table 4.34 The Mexican Drug Delivery Technologies Market: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 4.35 The Rest of the World’s Drug Delivery Technologies Market Forecast: Revenue ($bn), Market Share (%) and CAGR (%), 2013-2024
Table 4.36 The Rest of the World’s Drug Delivery Technologies Markets: Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.1 Leading Biopharmaceutical Drugs Driving the Drug Delivery Technologies Market: Total Sales ($bn), 2013
Table 5.2 Some Leading Monoclonal Antibody Drugs, 2013
Table 5.3 Monoclonal Antibodies: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.4 Insulins: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.5 Selected Interferon Products: Generic Name, Brand Name, Manufacturer, 2014
Table 5.6 Interferons: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.7 Erythropoietins: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.8 Granular-Colony Stimulating Factors (G-CSF): Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.9 Recombinant Coagulation Factors: Selected Products, 2014
Table 5.10 Recombinant Coagulation Factors: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.11 Human Growth Hormones: Selected Products, 2014
Table 5.12 Immunosuppressants: Selected Products, 2014
Table 5.13 Other Therapeutic Proteins: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.14 Biosimilars: Selected Products, 2014
Table 5.15 Biosimilars: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 5.16 Biosimilars: Selected Products, 2014
Table 5.17 Vaccines: Global Sales Forecast ($bn, AGR%, CAGR%), 2013-2024
Table 6.1 3M: Net Sales ($bn) by Franchise, 2013
Table 6.2 3M: Historical Healthcare Revenue ($bn, AGR %), 2008-2013
Table 6.3 Aradigm: Pipeline Products, 2014
Table 6.4 Vectura Group: Current Products and Description, 2014
Table 6.5 Vectura Group: Products Under Development, 2014
Table 6.6 Catalent Pharma: Historical Revenue ($m, AGR %), 2009-2013
Table 6.7 Emisphere Technologies: Historical Financial Information ($m) 2010-2012
Table 6.8 Ethypharm’s Pain Relieving Products, 2014
Table 6.9 Alkermes: Historical Revenue ($m, AGR %), 2009-2013
Table 6.10 Alkerme’s Product Pipeline, 2014
Table 6.11 Pacira Pharmaceuticals: Products and Therapeutic Indication, 2014
Table 6.12 Pacira Pharmaceuticals: Historical Revenue ($m, AGR %), 2009-2013
Table 6.13 Noven Pharmaceuticals: Products, Drug Delivery Systems, and Drug Marketers, 2014
Table 6.14 Noven Pharmaceuticals: Marketed and Pipeline Transdermal Products, 2014
Table 6.15 Columbia Laboratories: Historical Revenue ($m, AGR %), 2008-2013
Table 7.1 Drug Delivery Technologies: Market Drivers and Restraints 2014-2024
Table 7.2 SWOT Analysis of the drug delivery Technologies Market, 2014-2024
Table 7.3 Selected Leading Drugs Expected to Lose Patent Protection 2013-2015
Table 7.4 Monoclonal Antibody Therapies Approved by the FDA, 2004-2011
Table 9.1 Global Drug Delivery Technologies: Market Forecast ($bn, CAGR%), 2013, 2018, 2021, 2024
Table 9.2 Global Drug Delivery Technologies: Market Forecast ($bn) by Sector, 2013, 2018, 2021, 2024
Table 9.3 Global Drug Delivery Technologies: Market Share (%) by Region, 2013, 2018, 2021, 2024
List of Figures
Figure 1.1 The Global Over 65 Population: Forecast (millions, AGR%), 2013-2024
Figure 1.2 Global Drug Delivery Technologies Market Segmentation Overview
Figure 1.3 Biologic Drugs: Overview of Forecasted Drug Classes
Figure 2.1 Possible Mode of Administration for Biological Drugs
Figure 3.1 The Global Drug Delivery Technologies Market: Revenue ($bn) by Sector, 2013
Figure 3.2 The Global Drug Delivery Technologies Market: Market Forecast ($bn, AGR%), 2013-2024
Figure 3.3 Global Drug Delivery Technologies Market Forecast: CAGR (%) by Sector, 2013-2018
Figure 3.4 Global Drug Delivery Technologies Market Forecast: CAGR (%) by Sector, 2018-2024
Figure 3.5 Global Drug Delivery Technologies Market Forecast: CAGR (%) by Sector, 2013-2024
Figure 3.6 The Global Drug Delivery Technologies Market: Revenue ($bn) by Sector, 2013, 2018, 2024
Figure 3.7 The Global Drug Delivery Technologies Market: Market Share (%) by Sector, 2013
Figure 3.8 The Global Drug Delivery Technologies Market: Market Share (%) by Sector, 2018
Figure 3.9 The Global Drug Delivery Technologies Market: Market Share (%) by Sector, 2024
Figure 3.10 Oral Drug Delivery Technologies Market: Market Forecast ($bn, AGR%), 2013-2024
Figure 3.11 Inhalation Drug Delivery Technologies Market: Market Forecast ($bn, AGR%), 2013-2024
Figure 3.12 Injectable/Implants Drug Delivery Technologies Market: Market Forecast ($bn, AGR%), 2013-2024
Figure 3.13 Transdermal Drug Delivery Technologies Market: Market Forecast ($bn, AGR%), 2013-2024
Figure 3.14 Ocular Drug Delivery Technologies Market: Market Forecast ($bn, AGR%), 2013-2024
Figure 3.15 Nasal Drug Delivery Technologies Market: Market Forecast ($bn, AGR%), 2013-2024
Figure 4.1 The Global Drug Delivery Technologies Market: Revenue ($bn) by Region, 2013
Figure 4.2 US, EU5, Japan, China and South India Drug Delivery Technologies Market: Revenue Forecast ($bn), 2013-2024
Figure 4.3 Brazil, Russia, South Korea, and Mexico Drug Delivery Technologies Market: Revenue Forecast ($bn), 2013-2024
Figure 4.4 Drug Delivery Technologies Market Forecast: CAGR (%) by Region, 2013-2018
Figure 4.5 Drug Delivery Technologies Market Forecast: CAGR (%) by Region, 2018-2024
Figure 4.6 Drug Delivery Technologies Market Forecast: CAGR (%) by Region, 2013-2024
Figure 4.7 Drug Delivery Technologies Market Forecast: Market Shares (%) by Region, 2013
Figure 4.8 Drug Delivery Technologies Market Forecast: Market Shares (%) by Region, 2018
Figure 4.9 Drug Delivery Technologies Market Forecast: Market Shares (%) by Region, 2024
Figure 4.10 US Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.11 The EU5 Drug Delivery Technologies Market: Market Size ($bn) by Region, 2013
Figure 4.12 Germany, UK, France, Spain, and Italy Drug Delivery Technologies Market: Revenue Forecast ($bn), 2013-2024
Figure 4.13 The EU5 Drug Delivery Technologies Market: Market Shares (%) by Country, 2013
Figure 4.14 The EU5 Drug Delivery Technologies Market: Market Shares (%) by Country, 2018
Figure 4.15 The EU5 Drug Delivery Technologies Market: Market Shares (%) by Country, 2024
Figure 4.16 The German Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.17 The French Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.18 The UK Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.19 The Spanish Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.20 The Italian Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.21 The Japanese Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.22 Japanese Over-65 Population and Forecast (%): 2010, 2013, 2035, 2060
Figure 4.23 The Chinese Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.24 The Indian Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.25 The Brazilian Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.26 The Russian Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.27 The South Korean Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.28 The Mexican Drug Delivery Technologies Market: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 4.29 The Rest of the World’s Drug Delivery Technologies Markets: Revenue Forecast ($bn, AGR%), 2013-2024
Figure 5.1 Monoclonal Antibodies: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.2 Insulins: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.3 Interferons: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.4 Erythropoietins: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.5 Granular-Colony Stimulating Factors (G-CSF): Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.6 Recombinant Coagulation Factors: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.7 Other Therapeutic Proteins: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.8 Biosimilars: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 5.9 Vaccines: Global Sales Forecast ($bn, AGR%), 2013-2024
Figure 6.1 3M: Revenue Shares (%) by Franchise, 2013
Figure 6.2 3M: Historical Healthcare Revenue ($bn), 2008-2013
Figure 6.3 Catalent Pharma: Historical Revenue ($m, AGR%), 2009-2013
Figure 6.4 Emisphere Technologies: Historical Financial Information ($m) 2010-2012
Figure 6.5 Alkermes: Historical Revenue ($m), 2009-2013
Figure 6.6 Pacira Pharmaceuticals: Historical Revenue ($m), 2009-2013
Figure 6.7 Columbia Laboratories: Historical Revenue ($m), 2008-2013
Figure 7.1 Approaches to Drug Delivery in Biologics, 2014
Figure 9.1 Global Drug Delivery Technologies: Market Forecast ($bn), 2013, 2018, 2021, 2024
Figure 9.2 Global Drug Delivery Technologies: Market Forecast ($bn) by Sector, 2013-2024


【掲載企業】

3M
Abbott
Adamas Pharmaceuticals
Alexion
Alimera Sciences
Alkermes
Allergan
Alpha MOS
Amgen
Amylin Pharmaceuticals (Bristol-Myers Squibb)
Antares Pharma
Antigen Express Inc (Generex)
Applied Pharma Research
Aptuit
Aradigm Corporation
Astellas
Bausch & Lomb
Baxter International
Bayer Healthcare Pharmaceuticals
Berna Biotech
Biocad
Biocon
Biogen Idec
Bioject Medical Technologies
Biopartners
Biotechpharma
Boehringer Ingelheim
Cardinal Health
Catalent Pharma Solutions
Chiron Corporation
CIMA Labs (Cephalon)
Circassia
Columbia Laboratories
Conba Pharmaceutical
CSL Behring
CT Arzneimittel GmbH
Daiichi
Dendreon
Dong-A Socio Holdings
Dr Reddy’s Laboratories
Elan Corporation (Perrigo)
Eli Lilly
Elite Pharmaceuticals
Emisphere Technologies
Ethypharm
Eurofarma
Evotec
Ferring Pharmaceuticals
Flynn Pharma
Fresenius SE & Co
Genentech (Roche)
Generex Biotechnology Corporation
GeneScience Pharmaceuticals
Genmab
Genzyme (Sanofi)
Gilead Sciences
GlaxoSmithKline
Glycologic
Hospira
Human Genome Sciences
Janssen Biotech
Johnson & Johnson
Labtec
LG Life Sciences
MannKind
Medimetrics
Merck Serono
Millennium Pharma (Takeda)
Mitsubishi Tanabe Pharma
Molecular Profiles
MonoSol Rx
Mundi Pharma
Nanopass Technologies
Nektar Therapeutics
Nordic Bioscience
Novartis
Noven Pharmaceuticals (Hisamitsu Pharmaceuticals)
Novo Nordisk
Novogyne Pharmaceuticals
Pacira Pharmaceuticals
Par Pharmaceutical
Pfizer
pSivida Corporation
Ranbaxy
Regeneron
Roche Group
Sandoz
Sanofi-Aventis
Schering-Plough (Merck & Co)
Seattle Genetics
SHL Group
Sigma-Tau Pharmasource
SkyePharma PLC
Strativa Pharmaceuticals
Takeda
Talecris Biotherapeutics
Teva
The Blackstone Group
UCB
Upsher-Smith Laboratories
Vectura Group
Vestiq Pharmaceuticals
Wyeth Pharmaceuticals (Pfizer)
Organisations Mentioned in the Report
Agenzia Italiana del Farmaco (AIFA)
Center for Disease Control [US]
Federal Commission for the Protection against Sanitary Risks (COFEPRIS)
Johns Hopkins University [US]
Kresge Eye Institute (Wayne State University, Detroit, US)
National Institute for Health and Clinical Excellence (NICE)
National Institute for Population and Social Security Research (IPSS) [Japan]
Russian Corporation of Nanotechnologies (Rusnano)
The Research Foundation for Microbial Diseases of Osaka University [Japan]
University of Copenhagen
US Food and Drug Administration (FDA)
US Securities and Exchange Commission (SEC)


【レポートのキーワード】

ドラッグデリバリー、薬物送達、ドラッグデリバリーシステム

★調査レポート[ドラッグデリバリー技術市場(2014-2024)] ( Drug Delivery Technologies Market Forecast 2014-2024 / Visiongain-405315) 販売に関する免責事項
[ドラッグデリバリー技術市場(2014-2024)] ( Drug Delivery Technologies Market Forecast 2014-2024 / Visiongain-405315) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆